Memphis Pharmaceuticals & Chemical Industries reported earnings results for the nine months ended March 31, 2023. For the nine months, the company reported sales was EGP 440.47 million compared to EGP 406.51 million a year ago. Net income was EGP 35.06 million compared to EGP 21 million a year ago.